EUROLAB
usp-71-sterility-testing-of-injectable-pharmaceutical-products
Pharmaceutical Microbiology Testing ICH Q10 Pharmaceutical Quality System and Microbial ControlsICH Q6A Testing for Microbiological Attributes of Drug SubstancesICH Q7 GMP Guidelines for Microbial Control in APIsICH Q9 Risk-Based Approach to Microbial ContaminationISO 11737-1 Bioburden Testing for Medical Devices and Pharmaceutical PackagingISO 11737-2 Sterility Assurance and Validation for Pharmaceutical ComponentsISO 11930 Preservation Efficacy Testing for Topical PharmaceuticalsISO 14644-1 Cleanroom Classification for Pharmaceutical ManufacturingISO 14698-1 Biocontamination Control in CleanroomsISO 16212 Yeast and Mold Testing in Pharmaceutical Raw MaterialsISO 18415 Detection of Pathogenic Microorganisms in Non-Sterile ProductsISO 21149 Enumeration of Aerobic Mesophilic Bacteria in Cosmetic and PharmaJP XVII Bacterial Endotoxin Test for Injectable PharmaceuticalsJP XVII Microbial Limit Tests for Oral PreparationsJP XVII Sterility Test for Pharmaceutical ProductsPh. Eur. 2.6.1 Sterility Testing for Finished Pharmaceutical ProductsPh. Eur. 2.6.11 Detection of Pathogens in Veterinary PharmaceuticalsPh. Eur. 2.6.12 Microbial Contamination Testing of Non-Sterile ProductsPh. Eur. 2.6.13 Detection of Clostridia in Parenteral SolutionsPh. Eur. 2.6.14 Bacterial Endotoxins – Gel Clot MethodPh. Eur. 2.6.15 Test for Pseudomonas aeruginosa in Topical DrugsPh. Eur. 2.6.16 Test for Staphylococcus aureus in Creams and GelsPh. Eur. 2.6.2 Mycoplasma Detection in Cell-Based PharmaceuticalsPh. Eur. 2.6.25 Testing for Anaerobic Bacteria in Sterile ProductsPh. Eur. 2.6.27 Bacterial Endotoxin Testing in Parenteral DrugsPh. Eur. 2.6.30 Monitoring of Controlled EnvironmentsPh. Eur. 2.6.32 Control of Bacterial Contamination in Ophthalmic DrugsPh. Eur. 2.6.7 Mycobacteria Detection in BiopharmaceuticalsPh. Eur. 2.6.9 Test for Escherichia coli in Non-Sterile PharmaPh. Eur. 5.1.4 Microbiological Quality of Pharmaceutical PreparationsPh. Eur. 5.1.6 Alternative Methods for Microbiological Quality ControlPh. Eur. 5.1.8 Bioburden Limits in Parenteral ManufacturingUSP <1072> Disinfectants and Antiseptics Microbial Efficacy TestUSP <1111> Microbiological Examination of Non-Sterile ProductsUSP <1115> Bioburden Control of Non-Sterile Drug SubstancesUSP <1116> Microbiological Control of Clean Rooms and Controlled EnvironmentsUSP <1117> Microbial Best Practices for Pharmaceutical Lab PersonnelUSP <1207> Package Integrity Evaluation – Microbial Ingress TestUSP <1208> Integrity Testing for Sterile Barrier SystemsUSP <1223> Water Activity Determination in Drug ProductsUSP <1227> Validation of Microbial Recovery MethodsUSP <1229> Microbial Quality of Compendial Water SystemsUSP <1231> Water for Pharmaceutical Purposes – Microbiological TestingUSP <39> Bioburden Limit Testing for Bulk Active IngredientsUSP <39> Microbiological Quality of Compounding PharmaciesUSP <51> Preservative Effectiveness Testing of Multi-Dose PharmaceuticalsUSP <55> Biological Indicators for Sterilization ValidationUSP <61> Microbial Enumeration Tests for Raw Pharmaceutical MaterialsUSP <61>/<62> Microbial Limit Tests for Tablet and Capsule FormsUSP <62> Tests for Specified Microorganisms in Non-Sterile Products

USP <71> Sterility Testing of Injectable Pharmaceutical Products Laboratory Testing Service Provided by Eurolab

Standard-Related Information

The USP <71> Sterility Testing of Injectable Pharmaceutical Products is a laboratory testing service that ensures the sterility of injectable pharmaceutical products. This testing service is governed by various international and national standards, including:

  • ISO 14644-1:2015 (Cleanrooms and associated controlled environments Part 1: Classification of air cleanliness)
  • ASTM E1152-14 (Standard Guide for Evaluating the Suitability of Air-Filtered, Laminar Flow Workbenches and Clean Benches for Controlled Environments)
  • EN ISO 14698-1:2019 (Cleanrooms and associated controlled environments Part 1: Classification of air cleanliness)
  • TSE 1423:2008 (Sterility testing of injectable pharmaceutical products)
  • These standards outline the requirements for cleanroom facilities, equipment, personnel, and procedures to ensure the sterility of injectable pharmaceutical products. The USP <71> Sterility Testing of Injectable Pharmaceutical Products is a critical component of quality control in the pharmaceutical industry.

    Standard Requirements and Needs

    The USP <71> Sterility Testing of Injectable Pharmaceutical Products is necessary for several reasons:

  • Product Safety: Injectable pharmaceutical products must be sterile to prevent contamination and ensure product safety.
  • Regulatory Compliance: The USP <71> Sterility Testing of Injectable Pharmaceutical Products is a regulatory requirement for injectable pharmaceutical products.
  • Quality Assurance: This testing service ensures that the product meets quality standards and is free from contaminants.
  • Risk Assessment: Failure to perform this test can result in contamination, recalls, and financial losses.
  • Industries and sectors that require USP <71> Sterility Testing of Injectable Pharmaceutical Products include:

  • Pharmaceuticals
  • Biotechnology
  • Medical devices
  • Cosmetics
  • Food processing
  • The consequences of not performing this test are severe, including product recalls, financial losses, and damage to reputation.

    Test Conditions and Methodology

    The USP <71> Sterility Testing of Injectable Pharmaceutical Products is conducted using the following equipment and instruments:

  • Laminar flow workbenches or clean benches
  • Autoclaves
  • Incubators
  • Microscopes
  • Sterilization filters
  • The testing environment requires specific conditions, including temperature (20-25C), humidity (30-60), and air pressure.

    Test Reporting and Documentation

    The test results are documented and reported in a clear and concise manner. The report format and structure include:

  • Introduction
  • Materials and methods
  • Results
  • Discussion
  • Conclusion
  • The interpretation of test results is critical to ensuring product safety and quality.

    Why This Test Should Be Performed

    Performing the USP <71> Sterility Testing of Injectable Pharmaceutical Products has numerous benefits, including:

  • Product Safety: Ensures that products are sterile and free from contaminants.
  • Regulatory Compliance: Meets regulatory requirements for injectable pharmaceutical products.
  • Quality Assurance: Ensures that products meet quality standards.
  • Risk Assessment: Identifies potential risks and mitigates them.
  • Why Eurolab Should Provide This Service

    Eurolab is the ideal laboratory to provide this service due to its:

  • Expertise and experience in USP <71> Sterility Testing of Injectable Pharmaceutical Products
  • State-of-the-art equipment and facilities
  • Qualified and certified personnel
  • Accreditation and certification details
  • International recognition and partnerships
  • Conclusion

    The USP <71> Sterility Testing of Injectable Pharmaceutical Products is a critical component of quality control in the pharmaceutical industry. This testing service ensures product safety, regulatory compliance, and quality assurance. Eurolabs expertise, equipment, and personnel make it an ideal laboratory to provide this service.

    Table 1: Standard Requirements

    Standard Title Scope

    --- --- ---

    ISO 14644-1:2015 Cleanrooms and associated controlled environments Part 1: Classification of air cleanliness Classifies air cleanliness in cleanrooms and associated controlled environments

    ASTM E1152-14 Standard Guide for Evaluating the Suitability of Air-Filtered, Laminar Flow Workbenches and Clean Benches for Controlled Environments Provides guidelines for evaluating the suitability of air-filtered, laminar flow workbenches and clean benches for controlled environments

    EN ISO 14698-1:2019 Cleanrooms and associated controlled environments Part 1: Classification of air cleanliness Classifies air cleanliness in cleanrooms and associated controlled environments

    TSE 1423:2008 Sterility testing of injectable pharmaceutical products Provides guidelines for sterility testing of injectable pharmaceutical products

    Table 2: Test Equipment and Instruments

    Equipment/Instrument Description

    --- ---

    Laminar flow workbenches or clean benches Provide a sterile environment for testing

    Autoclaves Sterilize equipment and materials

    Incubators Maintain controlled temperatures for testing

    Microscopes Examine samples for contamination

    Table 3: Test Environment Requirements

    Parameter Value

    --- ---

    Temperature 20-25C

    Humidity 30-60

    Air pressure Normal atmospheric pressure

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers